Affilogic
Created in 2010
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
2,553Activities
Technologies
Entity types
Location
24 Rue de la Rainière, 44300 Nantes, France
Nantes
France
Employees
Scale: 11-50
Estimated: 37
SIREN
520079682Engaged corporates
4
4 1Added in Motherbase
3 years, 8 months ago
biotech Value proposition
Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders
Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector.
These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule.
Affilogic has designed Nanofitins® against 60+ targets to date, including a wide range of circulating antigens (peptides, proteins), membrane receptors for inhibition / modulation (GPCR, ion channels) and complex entities (virus-like particles, bacteria, whole cells).
Non-systemic delivery, Nanofitin-Drug-Conjugates, and Multi-specific NanofitinsOriginal language
Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders
Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector.
These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule.
Affilogic has designed Nanofitins® against 60+ targets to date, including a wide range of circulating antigens (peptides, proteins), membrane receptors for inhibition / modulation (GPCR, ion channels) and complex entities (virus-like particles, bacteria, whole cells).
Affilogic: Binding proteins, as alternative scaffolds antibody-mimetics
Affilogic is a biotech company developing a new class of binding proteins, Nanofitins®, which constitute a robust and affordable alternative to antibodies. Learn more!
https://www.affilogic.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 14 Nov 2024 | | |
 | Gouvernement | Other 25 Jan 2023 | | |
 Atlanpole Business Consulting and Services | Atlanpole Business Consulting and Services | Other 21 Sep 2023 | | |
 Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 7 Jun 2024 | | |